Your browser doesn't support javascript.
loading
Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients.
Nteliopoulos, Georgios; Page, Karen; Hills, Allison; Howarth, Karen; Emmett, Warren; Green, Emma; Martinson, Luke J; Fernadez-Garcia, Daniel; Hastings, Robert; Guttery, David S; Kenny, Laura; Stebbing, Justin; Cleator, Susan; Rehman, Farah; Gleason, Kelly L T; Sanela, Andrijac; Ion, Charlotte; Rushton, Amelia J; Rosenfeld, Nitzan; Coombes, R Charles; Shaw, Jacqueline A.
Afiliación
  • Nteliopoulos G; Department of Surgery and Cancer, Division of Cancer, Imperial College London, London, UK.
  • Page K; Department of Genetics and Genome Biology and Leicester Cancer Research Centre, College of Life Sciences, University of Leicester, University Road, Leicester, LE1 7RH, UK.
  • Hills A; Department of Surgery and Cancer, Division of Cancer, Imperial College London, London, UK.
  • Howarth K; Inivata Ltd, Granta Park, Cambridge, UK.
  • Emmett W; Inivata Ltd, Granta Park, Cambridge, UK.
  • Green E; Inivata Ltd, Granta Park, Cambridge, UK.
  • Martinson LJ; Department of Genetics and Genome Biology and Leicester Cancer Research Centre, College of Life Sciences, University of Leicester, University Road, Leicester, LE1 7RH, UK.
  • Fernadez-Garcia D; Department of Genetics and Genome Biology and Leicester Cancer Research Centre, College of Life Sciences, University of Leicester, University Road, Leicester, LE1 7RH, UK.
  • Hastings R; Department of Genetics and Genome Biology and Leicester Cancer Research Centre, College of Life Sciences, University of Leicester, University Road, Leicester, LE1 7RH, UK.
  • Guttery DS; Department of Genetics and Genome Biology and Leicester Cancer Research Centre, College of Life Sciences, University of Leicester, University Road, Leicester, LE1 7RH, UK.
  • Kenny L; Department of Medical Oncology, Imperial College London, Charing Cross Hospital, London, UK.
  • Stebbing J; Department of Medical Oncology, Imperial College London, Charing Cross Hospital, London, UK.
  • Cleator S; Department of Medical Oncology, Imperial College London, Charing Cross Hospital, London, UK.
  • Rehman F; Department of Medical Oncology, Imperial College London, Charing Cross Hospital, London, UK.
  • Gleason KLT; Department of Medical Oncology, Imperial College London, Charing Cross Hospital, London, UK.
  • Sanela A; Department of Medical Oncology, Imperial College London, Charing Cross Hospital, London, UK.
  • Ion C; Department of Medical Oncology, Imperial College London, Charing Cross Hospital, London, UK.
  • Rushton AJ; Department of Surgery and Cancer, Division of Cancer, Imperial College London, London, UK.
  • Rosenfeld N; Inivata Ltd, Granta Park, Cambridge, UK.
  • Coombes RC; Department of Surgery and Cancer, Division of Cancer, Imperial College London, London, UK.
  • Shaw JA; Department of Genetics and Genome Biology and Leicester Cancer Research Centre, College of Life Sciences, University of Leicester, University Road, Leicester, LE1 7RH, UK. js39@le.ac.uk.
Breast Cancer Res Treat ; 188(2): 465-476, 2021 Jul.
Article en En | MEDLINE | ID: mdl-34097174
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / ADN Tumoral Circulante Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / ADN Tumoral Circulante Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido